Stock listing
NASDAQ:FOCL Edap Tms SA Stock
Follow Edap Tms SA into a list and get an email when it puts out news.
Share price · NASDAQ:FOCL
$2.61 USD -0.49 (-15.8%)
Close on Nov 20, 2026
- Day range
- $2.55 – $3.10 USDNov 20, 2026
- Volume
- 143,147 sharesNov 20, 2026
- Market cap
- $123.2M USDAt the close on Nov 20, 2026 · price × 47.22M shares outstanding
- 52-week range
- $2.11 – $6.40 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $307,963 USDMedian day 65,000 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:FOCL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.61 | -0.49 | -15.8% | $2.80 | $3.10 | $2.55 | 143,147 | |
| $3.10 | +0.26 | +9.2% | $2.90 | $3.34 | $2.80 | 159,119 | |
| $2.84 | -0.33 | -10.4% | $2.96 | $3.12 | $2.80 | 101,850 | |
| $3.17 | -0.075 | -2.3% | $3.25 | $3.39 | $3.155 | 89,446 | |
| $3.245 | -0.165 | -4.8% | $3.51 | $3.51 | $3.245 | 53,715 | |
| $3.41 | -0.12 | -3.4% | $3.55 | $3.57 | $3.40 | 52,359 | |
| $3.53 | +0.03 | +0.9% | $3.56 | $3.57 | $3.46 | 36,304 | |
| $3.50 | -0.02 | -0.6% | $3.49 | $3.56 | $3.44 | 102,973 | |
| $3.52 | +0.20 | +6.0% | $3.32 | $3.89 | $3.32 | 144,985 | |
| $3.32 | -0.93 | -21.9% | $4.16 | $4.48 | $3.28 | 376,400 | |
| $4.25 | -0.09 | -2.1% | $4.38 | $4.38 | $4.14 | 51,000 | |
| $4.34 | +0.23 | +5.6% | $4.24 | $4.40 | $4.24 | 7,900 | |
| $4.11 | -0.23 | -5.3% | $4.22 | $4.41 | $4.07 | 35,100 | |
| $4.34 | +0.16 | +3.8% | $4.28 | $4.37 | $4.16 | 27,000 | |
| $4.18 | +0.01 | +0.2% | $4.30 | $4.41 | $4.10 | 66,100 | |
| $4.17 | -0.09 | -2.1% | $4.24 | $4.37 | $4.15 | 42,100 | |
| $4.26 | +0.14 | +3.4% | $4.13 | $4.42 | $4.13 | 33,000 | |
| $4.12 | -0.11 | -2.6% | $4.30 | $4.30 | $4.05 | 10,200 | |
| $4.23 | +0.06 | +1.4% | $4.23 | $4.37 | $4.13 | 6,700 | |
| $4.17 | +0.02 | +0.5% | $4.48 | $4.48 | $4.13 | 27,400 | |
| $4.15 | -0.22 | -5.0% | $4.28 | $4.39 | $4.15 | 30,700 | |
| $4.37 | +0.17 | +4.0% | $4.18 | $4.42 | $4.18 | 55,800 | |
| $4.20 | +0.13 | +3.2% | $4.14 | $4.26 | $4.12 | 11,100 | |
| $4.07 | -0.02 | -0.5% | $4.12 | $4.22 | $4.05 | 64,600 | |
| $4.09 | -0.04 | -1.0% | $4.30 | $4.30 | $3.97 | 85,100 | |
| $4.13 | +0.14 | +3.5% | $4.00 | $4.27 | $4.00 | 59,500 | |
| $3.99 | -0.21 | -5.0% | $4.18 | $4.30 | $3.99 | 70,900 | |
| $4.20 | -0.10 | -2.3% | $4.26 | $4.34 | $4.19 | 50,500 | |
| $4.30 | +0.11 | +2.6% | $4.05 | $4.38 | $4.05 | 12,100 | |
| $4.19 | +0.06 | +1.5% | $4.23 | $4.40 | $4.11 | 76,300 | |
| $4.13 | -0.06 | -1.4% | $4.13 | $4.37 | $4.10 | 16,500 | |
| $4.19 | -0.08 | -1.9% | $4.24 | $4.40 | $4.18 | 71,200 | |
| $4.27 | +0.04 | +0.9% | $4.24 | $4.48 | $4.24 | 5,200 | |
| $4.23 | +0.03 | +0.7% | $4.25 | $4.40 | $4.20 | 93,000 | |
| $4.20 | -0.12 | -2.8% | $4.28 | $4.41 | $4.16 | 52,900 | |
| $4.32 | -0.15 | -3.4% | $4.48 | $4.76 | $4.30 | 124,400 | |
| $4.47 | -0.07 | -1.5% | $4.53 | $4.66 | $4.41 | 95,000 | |
| $4.54 | +0.01 | +0.2% | $4.53 | $4.75 | $4.53 | 65,000 | |
| $4.53 | -0.18 | -3.8% | $4.74 | $4.77 | $4.47 | 116,500 | |
| $4.71 | +0.12 | +2.6% | $4.67 | $4.76 | $4.58 | 59,500 | |
| $4.59 | -0.15 | -3.2% | $4.64 | $4.64 | $4.42 | 40,600 | |
| $4.74 | +0.47 | +11.0% | $4.28 | $4.75 | $4.16 | 143,100 | |
| $4.27 | +0.03 | +0.7% | $4.21 | $4.43 | $4.17 | 104,500 | |
| $4.24 | +0.09 | +2.2% | $4.10 | $4.27 | $4.10 | 87,200 | |
| $4.15 | -0.13 | -3.0% | $4.29 | $4.29 | $4.05 | 104,800 | |
| $4.28 | +0.21 | +5.2% | $4.07 | $4.28 | $4.02 | 105,200 | |
| $4.07 | -0.01 | -0.2% | $4.12 | $4.15 | $4.00 | 64,800 | |
| $4.08 | -0.03 | -0.7% | $4.14 | $4.20 | $4.08 | 39,600 | |
| $4.11 | +0.01 | +0.2% | $4.10 | $4.12 | $4.01 | 59,900 | |
| $4.10 | -0.06 | -1.4% | $4.20 | $4.23 | $4.02 | 66,300 | |
| $4.16 | -0.04 | -1.0% | $4.12 | $4.30 | $4.09 | 112,900 | |
| $4.20 | -0.01 | -0.2% | $4.12 | $4.26 | $4.12 | 87,400 | |
| $4.21 | +0.06 | +1.4% | $4.16 | $4.30 | $4.11 | 109,700 | |
| $4.15 | -0.02 | -0.5% | $4.18 | $4.24 | $4.15 | 102,800 | |
| $4.17 | -0.05 | -1.2% | $4.27 | $4.40 | $4.17 | 32,100 | |
| $4.22 | -0.09 | -2.1% | $4.30 | $4.35 | $4.17 | 113,000 | |
| $4.31 | +0.04 | +0.9% | $4.26 | $4.38 | $4.21 | 71,200 | |
| $4.27 | -0.04 | -0.9% | $4.31 | $4.38 | $4.25 | 18,600 | |
| $4.31 | -0.03 | -0.7% | $4.39 | $4.47 | $4.30 | 30,400 | |
| $4.34 | -0.07 | -1.6% | $4.42 | $4.50 | $4.30 | 81,100 | |
| $4.41 | +0.02 | +0.5% | $4.35 | $4.49 | $4.28 | 57,800 | |
| $4.39 | +0.21 | +5.0% | $4.12 | $4.47 | $4.12 | 55,043 | |
| $4.18 | +0.05 | +1.2% | $4.175 | $4.24 | $4.01 | 129,968 | |
| $4.13 | -0.11 | -2.6% | $4.23 | $4.24 | $4.08 | 236,400 | |
| $4.24 | -0.12 | -2.8% | $4.30 | $4.34 | $4.22 | 175,900 |
- Ticker
- NASDAQ:FOCL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026
Latest deck · Aug 11, 2026
Q2 2026 Earnings Presentation
Earnings · 45 slides
Latest news
FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026
Oct 22, 2026
Closed $4.17 (+0.5%) on Oct 23, 2026
Edap Tms SA on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 1 in the last 12 months · 1 in all · newest Oct 22, 2026 · oldest 2026
- Decks
- 8 decks · latest Aug 11, 2026
Valuation
EV/sales 1.3× against a median of 0.6×: 7th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $103.0M USD
- P/E
- Loss
- EV/sales
- 1.3×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 3.4×
- Gross margin
- 45.2%
- Operating margin
- −35.4%
- Net margin
- −47.0%
- Debt to equity
- 1.0×
- Beta vs S&P 500
- 1.17
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Edap Tms SA · NASDAQ:FOCL | US$123.2M | US$103.0M | n/a | 1.3× | n/a | 3.4× | −47.0% | 1.0× | 1.17 |
| Hans Biomed Corp · KRX:042520 | US$135.1M | US$125.0M | n/a | 1.4× | n/a | 2.3× | −15.8% | 0.1× | n/a |
| MicroTech Medical (Hangzhou) Co., Ltd. Class H · HKEX:2235 | US$127.9M | −US$86.44M | 21.2× | −0.9× | −10.0× | 0.4× | 6.1% | 0.1× | n/a |
| Mercator Medical SA · GPW:MRC | US$123.9M | US$87.97M | 7.6× | 0.6× | 4.5× | 0.5× | 10.7% | 0.0× | n/a |
| i-SENS, Inc. · KRX:099190 | US$123.6M | US$118.2M | n/a | 0.5× | 5.6× | 0.5× | −0.8% | 0.2× | n/a |
| St.Shine Optical Co., Ltd. · TPEX:1565 | US$117.8M | US$48.97M | 8.5× | 0.4× | 2.0× | 0.6× | 11.1% | 0.0× | n/a |
| MediNice SA · GPW:ICE | US$114.5M | US$113.6M | n/a | n/a | n/a | 5.5× | n/a | 0.0× | n/a |
| Allgens Medical Technology Co. Ltd. Class A · SSE:688613 | US$112.7M | −US$36.23M | 94.7× | −1.1× | n/a | 0.5× | 3.5% | 0.0× | n/a |
| Aroa Biosurgery Ltd · ASX:ARX | US$112.7M | US$101.2M | 40.9× | 1.7× | 16.9× | 2.1× | 4.5% | 0.1× | n/a |
| Pulmonx Corporation · NASDAQ:LUNG | US$111.9M | US$97.15M | n/a | 1.1× | n/a | 3.3× | −47.9% | 1.1× | 1.95 |
| Laxmi Dental Ltd. · NSE:LAXMIDENTL | US$111.4M | US$110.1M | 31.9× | 3.5× | 20.4× | 3.9× | 11.0% | 0.1× | n/a |
| Median of the others | US$116.2M | US$99.17M | 26.5× | 0.6× | 5.1× | 1.3× | 4.5% | 0.1× | 1.95 |
Forecasts
3 strong buy · 2 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 8.30 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.88 · 2 analysts
- Revenue, year to Dec 2026
- 51.01M · 5 analysts
Team and board
| Officer | Role |
|---|---|
| Ryan Rhodes | Chief Executive Officer |
| Ken Mobeck | Chief Financial Officer |
| Sanket Shah | General Counsel & Corporate Secretary |
| Anil Madhireddy | Vice President, Information Technology |
| Hugo Embert | Vice President, Marketing & Reimbursement |
| Michelle Montakhab | Vice President, People, Talent & Culture |
| Steve Annen | Executive Vice President, Marketing & Product Management |
| Mohan Nathan | Sr. Vice President, US Sales |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · After close | −21.9% |
| Q2 2026 | Aug 13, 2026 · After close | +2.8% |
| Q1 2026 | May 7, 2026 · Before open | +15.6% |
| Q4 2025 | Mar 25, 2026 | −3.6% |
| Q3 2025 | Nov 6, 2025 · Before open | −4.3% |
| Q2 2025 | Aug 28, 2025 | +43.0% |
| Q1 2025 | May 15, 2025 · Before open | −18.5% |
| Q4 2024 | Mar 27, 2025 | +4.9% |
| Q3 2024 | Nov 7, 2024 · Before open | −3.9% |
| Q2 2024 | Aug 28, 2024 | +13.6% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 16, 2024 | −2.5% |
| Q4 2023 | Mar 27, 2024 · Before open | −2.7% |
| Q3 2023 | Nov 9, 2023 · Before open | −26.9% |
| Q2 2023 | Aug 24, 2023 · Before open | −0.1% |
| Q1 2023 | May 17, 2023 · Before open | +1.2% |
| Q4 2022 | Mar 30, 2023 | −0.5% |
| Q3 2022 | Nov 16, 2022 · After close | +4.0% |
| Q2 2022 | Aug 24, 2022 · After close | +14.7% |
| Q1 2022 | May 17, 2022 · After close | +5.1% |
| Quarter to Sep 30, 2021 | Nov 17, 2021 · After close | −3.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 45 slides | Aug 11, 2026 |
| Investor Presentation (August 2026) | Investor deck | 43 slides | August 2026 |
| H.C. Wainwright 28th Annual Global Investment Conference (August 2026) | Conference | 21 slides | August 2026 |
| FocalTherics — Investor Day (June 2026) | Investor day | 113 slides | Jun 1, 2026 |
| Investor Presentation (March 2026) | Investor deck | 33 slides | Mar 18, 2026 |
| Investor Presentation (January 2026) | Investor deck | 49 slides | Jan 12, 2026 |
| Investor Presentation (July 2006) | Investor deck | 28 slides | Jul 27, 2006 |
| Investor Presentation (January 2006) | Investor deck | 46 slides | Jan 17, 2006 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 70.5M | 69.4M | 65.3M | 57.9M | 52.1M | 47.5M | 50.3M | 46.2M | 40.3M | 39.4M |
| Cost of revenue | 40.5M | 40.7M | 38.9M | 32.5M | 30.3M | 26.5M | 26.8M | 26.3M | 23.6M | 21.2M |
| Gross profit | 30.0M | 28.7M | 26.4M | 25.4M | 21.8M | 21.0M | 23.5M | 20.0M | 16.7M | 18.2M |
| Research and development | 9.66M | 8.36M | 8.21M | 6.04M | 5.62M | 5.90M | 5.29M | 5.63M | 4.38M | 4.28M |
| Selling, general and administrative | 45.0M | 41.2M | 25.2M | |||||||
| Operating income | -24.7M | -22.2M | -22.1M | -5.35M | -3.51M | -464.0K | 1.35M | -2.36M | -2.29M | 432.5K |
| Depreciation and amortization | 3.41M | 2.78M | 2.08M | 1.72M | 2.27M | 2.52M | 2.32M | 1.74M | 1.77M | 1.13M |
| EBITDA | -21.3M | -19.4M | -20.0M | -3.63M | -1.24M | 2.05M | 3.67M | -617.0K | -512.1K | 1.57M |
| Interest expense | 789.0K | 256.0K | 250.8K | 176.6K | 61.5K | 123.1K | 185.8K | 131.0K | 49.6K | 63.1K |
| Income before tax | -28.8M | -20.3M | -22.6M | -2.81M | 326.2K | -1.92M | 1.60M | -784.5K | -330.5K | 4.92M |
| Income tax | 438.0K | 313.0K | 252.7K | 269.0K | -501.2K | 27.4K | -92.9K | -385.8K | 437.6K | 665.9K |
| Net income | -29.2M | -20.6M | -22.9M | -3.08M | 827.4K | -1.94M | 1.69M | -398.8K | -768.1K | 4.25M |
| Earnings per share, basic | -0.78 | -0.55 | -0.62 | -0.09 | 0.03 | -0.07 | 0.06 | -0.01 | -0.03 | 0.14 |
| Earnings per share, diluted | -0.78 | -0.55 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 20.5M | 31.0M | 48.0M | 67.4M | 53.7M | 30.2M | 23.4M | 22.3M | 24.0M | 23.2M |
| Short-term investments | 0 | |||||||||
| Receivables | 14.9M | 19.3M | 21.3M | 15.9M | 13.8M | 15.1M | 14.1M | 15.2M | 14.8M | 10.6M |
| Inventory | 7.77M | 19.2M | 16.7M | 12.6M | 8.53M | 9.77M | 9.18M | 8.24M | 8.09M | 8.47M |
| Current assets | 57.2M | 72.6M | 86.7M | 96.6M | 76.6M | 55.5M | 47.3M | 46.2M | 47.5M | 42.7M |
| Property, plant and equipment | 9.88M | 7.57M | ||||||||
| Goodwill | 757.0K | 2.50M | 2.66M | 2.57M | 2.74M | 2.95M | 2.71M | 2.76M | 2.90M | 2.54M |
| Total assets | 79.0M | 89.4M | 101.1M | 107.9M | 87.8M | 67.5M | 59.6M | 55.7M | 56.3M | 49.1M |
| Accounts payable | 11.8M | 12.4M | 7.09M | 6.27M | 6.98M | 6.79M | 7.20M | 7.58M | 6.29M | |
| Current liabilities | 37.1M | 39.3M | 30.5M | 23.2M | 20.4M | 26.3M | 19.6M | 19.2M | 19.4M | 15.8M |
| Long-term debt | 15.9M | 2.25M | 2.21M | 3.85M | ||||||
| Total debt | 22.4M | 11.2M | 9.37M | 10.0M | 11.4M | 13.6M | 9.72M | 7.71M | 5.67M | 2.91M |
| Total liabilities | 59.6M | 46.9M | 38.2M | 31.5M | 30.9M | 34.1M | 27.7M | 26.0M | 24.9M | 23.1M |
| Shareholders' equity | 19.4M | 42.5M | 62.9M | 76.4M | 56.9M | 32.1M | 30.7M | 28.5M | 30.2M | 25.8M |
| Shares outstanding | 37.5M | 37.4M | 37.0M | 34.4M | 32.4M | 29.1M | 29.6M | 29.0M | 29.0M | 29.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -16.4M | -14.7M | -15.9M | -3.18M | 5.26M | 2.25M | 4.25M | 206.5K | -3.45M | 1.34M |
| Capital spending | -4.94M | -1.27M | -644.2K | -464.5K | -605.3K | -443.2K | -712.6K | -711.7K | -355.1K | |
| Free cash flow | -21.4M | -17.1M | -3.82M | 4.79M | 1.65M | 3.81M | -506.1K | -4.16M | 982.3K | |
| Cash from investing | -5.71M | -4.46M | -4.70M | -2.50M | -1.94M | -2.29M | -1.71M | -1.85M | -2.29M | -424.8K |
| Cash from financing | 8.61M | 5.02M | -984.9K | 22.8M | 24.0M | 3.65M | -743.2K | 1.39M | 3.24M | 8.41M |
| Change in cash | -10.5M | -17.0M | -19.4M | 13.7M | 23.4M | 6.77M | 1.19M | -1.77M | 827.9K | 8.44M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 19, 2026 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Sep 15, 2026 | Offer document | SEC |
| 3 · Initial statement of ownership | Aug 20, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 19, 2026 | Current report | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
Show 200 filings
This page holds 200 of 497 filings. Open Filings
Cap table
Built by 6ix from Edap Tms SA’s releases
- Common shares
- 47,216,700
- Fully diluted
- 47,216,700
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 47,216,700 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 47,216,700 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joshua Levine Other companies: PishPosh, Inc. (Director · Jun 22, 2018 – Jul 21, 2022 · Past); Accuray Incorporated (CEO, Director · Oct 11, 2012 – Sep 30, 2021 · Past); Immucor Inc (President and CEO, Director · Jun 9, 2011 – Aug 19, 2011 · Past); Mentor Corp (CEO, Director · Jul 13, 2006 – Jan 16, 2009 · Past) | Director · Since at least Jan 1, 2026 |
| Lance Willsey Other companies: EXACT Sciences Corporation (Director · Jul 21, 2006 – Jul 20, 2009 · Past); Exelixis, Inc. (Director · May 2, 2006 – May 26, 2022 · Past) | Director · Since at least Jan 1, 2026 |
| David R Horn Other companies: Seer, Inc. (PRESIDENT & CFO · Since at least Dec 3, 2020) | Director · Since at least Feb 11, 2026 |
| Fran Schulz Other companies: Senti Biosciences Holdings, Inc. (Director · Since at least Dec 9, 2024) | Director · Since at least Jan 1, 2026 |
| Glendon E French III Other companies: Pulmonx Corporation (President and CEO, Director · Since at least Sep 30, 2020) | Director · Since at least Jan 1, 2026 |
| Ryan Rhodes Other companies: Venus Concept Inc (President and CEO, Director · Oct 11, 2017 – Nov 16, 2018 · Past) | Chief Executive Officer · Since at least Jan 1, 2026 |
| Steven Annen Other companies: Invuity Inc (VP Product Mngmnt and Strategy · Apr 21, 2016 – Oct 23, 2018 · Past) | SVP, Marketing & Product Mgmt. · Since at least Jan 1, 2026 |
| Anil Madhireddy | Vice President, Information Technology · Since at least Nov 5, 2026 |
| Francois Mattieu Dietsch | Chief Accounting Officer · Since at least Jan 1, 2026 |
| Hugo Embert | Vice President, Marketing & Reimbursement · Since at least Nov 5, 2026 |
All 16 people
| Person | Seat |
|---|---|
| Ken Mobeck | Chief Financial Officer · Since at least Oct 22, 2026 |
| Kenneth S Mobeck | Chief Financial Officer · Since at least Jan 1, 2026 |
| Michelle Montakhab | Vice President, People, Talent & Culture · Since at least Nov 5, 2026 |
| Mohan Nathan | Sr. Vice President, US Sales · Since at least Nov 5, 2026 |
| Sanket Shah | General Counsel & Corp Sec · Since at least Jan 1, 2026 |
| Steve Annen | Executive Vice President, Marketing & Product Management · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Edap Tms SA.